Demographical and clinical characteristics of the study cohort
Patients (n = 174) | |
---|---|
AZA, azathioprine; CD, Crohn’s disease; IFX, infliximab; IS, immunosuppression; IQR, interquartile range; MTX, methotrexate; WBC, white blood cell. | |
Values are given as n (%) unless otherwise specified. | |
Female | 107 (61.5) |
Mean age (range years) | 39 (18–73) |
Mean age at first IFX (range; years) | 35 (14/72) |
Indication for IFX | |
Luminal CD | 138 (79) |
Fistulising CD | 36 (21) |
Disease location | |
Ileitis | 36 (21) |
Ileocolitis | 84 (48) |
Colitis | 54 (31) |
Concomitant IS therapy | |
No IS | 59 (34.0) |
AZA | 65 (37.3) |
MTX | 50 (28.7) |
Active smoking | 45 (25.9) |
Median WBC baseline (IQR) | 7.800 (6.125–9.875) |